Isolation of a Klebsiella pneumoniae isolate of sequence type 258 producing KPC-2 carbapenemase in Korea

Kyoung Ho Roh, Chang Kyu Lee, Jang Wook Sohn, Wonkeun Song, DongEun Yong, Kyungwon Lee

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Carbapenem-resistant Klebsiella pneumoniae isolates producing K. pneumoniae carbapenemases (KPC) were first reported in the USA in 2001, and since then, this infection has been reported in Europe, Israel, South America, and China. In Korea, the first KPC-2-producing K. pneumoniae sequence type (ST) 11 strain was detected in 2010. We report the case of a patient with a urinary tract infection caused by KPC-2-producing K. pneumoniae. This is the second report of a KPC-2-producing K. pneumoniae infection in Korea, but the multilocus sequence type was ST258. The KPC-2-producing isolate was resistant to all tested β-lactams (including imipenem and meropenem), amikacin, tobramycin, ciprofloxacin, levofloxacin, and trimethoprim-sulfamethoxazole, but was susceptible to gentamicin, colistin, polymyxin B, and tigecycline. The KPC-2-producing isolate was negative to phenotypic extended-spectrum β-lactamase (ESBL) and AmpC detection tests and positive to modified Hodge test and carbapenemase inhibition test with aminophenylboronic acid.

Original languageEnglish
Pages (from-to)298-301
Number of pages4
JournalKorean Journal of Laboratory Medicine
Volume31
Issue number4
DOIs
Publication statusPublished - 2011 Oct 31

Fingerprint

meropenem
Colistin
Lactams
Polymyxin B
Levofloxacin
Tobramycin
Carbapenems
Amikacin
Imipenem
Sulfamethoxazole Drug Combination Trimethoprim
Klebsiella pneumoniae
Korea
Ciprofloxacin
Gentamicins
Klebsiella Infections
3-aminobenzeneboronic acid
tigecycline
carbapenemase
Klebsiella pneumoniae carbapenemase-2
South America

All Science Journal Classification (ASJC) codes

  • Biochemistry, medical
  • Clinical Biochemistry

Cite this

@article{e1b3db8cef8844779527ad3c02766819,
title = "Isolation of a Klebsiella pneumoniae isolate of sequence type 258 producing KPC-2 carbapenemase in Korea",
abstract = "Carbapenem-resistant Klebsiella pneumoniae isolates producing K. pneumoniae carbapenemases (KPC) were first reported in the USA in 2001, and since then, this infection has been reported in Europe, Israel, South America, and China. In Korea, the first KPC-2-producing K. pneumoniae sequence type (ST) 11 strain was detected in 2010. We report the case of a patient with a urinary tract infection caused by KPC-2-producing K. pneumoniae. This is the second report of a KPC-2-producing K. pneumoniae infection in Korea, but the multilocus sequence type was ST258. The KPC-2-producing isolate was resistant to all tested β-lactams (including imipenem and meropenem), amikacin, tobramycin, ciprofloxacin, levofloxacin, and trimethoprim-sulfamethoxazole, but was susceptible to gentamicin, colistin, polymyxin B, and tigecycline. The KPC-2-producing isolate was negative to phenotypic extended-spectrum β-lactamase (ESBL) and AmpC detection tests and positive to modified Hodge test and carbapenemase inhibition test with aminophenylboronic acid.",
author = "Roh, {Kyoung Ho} and Lee, {Chang Kyu} and Sohn, {Jang Wook} and Wonkeun Song and DongEun Yong and Kyungwon Lee",
year = "2011",
month = "10",
day = "31",
doi = "10.3343/kjlm.2011.31.4.298",
language = "English",
volume = "31",
pages = "298--301",
journal = "Annals of Laboratory Medicine",
issn = "2234-3806",
publisher = "Seoul National University",
number = "4",

}

Isolation of a Klebsiella pneumoniae isolate of sequence type 258 producing KPC-2 carbapenemase in Korea. / Roh, Kyoung Ho; Lee, Chang Kyu; Sohn, Jang Wook; Song, Wonkeun; Yong, DongEun; Lee, Kyungwon.

In: Korean Journal of Laboratory Medicine, Vol. 31, No. 4, 31.10.2011, p. 298-301.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Isolation of a Klebsiella pneumoniae isolate of sequence type 258 producing KPC-2 carbapenemase in Korea

AU - Roh, Kyoung Ho

AU - Lee, Chang Kyu

AU - Sohn, Jang Wook

AU - Song, Wonkeun

AU - Yong, DongEun

AU - Lee, Kyungwon

PY - 2011/10/31

Y1 - 2011/10/31

N2 - Carbapenem-resistant Klebsiella pneumoniae isolates producing K. pneumoniae carbapenemases (KPC) were first reported in the USA in 2001, and since then, this infection has been reported in Europe, Israel, South America, and China. In Korea, the first KPC-2-producing K. pneumoniae sequence type (ST) 11 strain was detected in 2010. We report the case of a patient with a urinary tract infection caused by KPC-2-producing K. pneumoniae. This is the second report of a KPC-2-producing K. pneumoniae infection in Korea, but the multilocus sequence type was ST258. The KPC-2-producing isolate was resistant to all tested β-lactams (including imipenem and meropenem), amikacin, tobramycin, ciprofloxacin, levofloxacin, and trimethoprim-sulfamethoxazole, but was susceptible to gentamicin, colistin, polymyxin B, and tigecycline. The KPC-2-producing isolate was negative to phenotypic extended-spectrum β-lactamase (ESBL) and AmpC detection tests and positive to modified Hodge test and carbapenemase inhibition test with aminophenylboronic acid.

AB - Carbapenem-resistant Klebsiella pneumoniae isolates producing K. pneumoniae carbapenemases (KPC) were first reported in the USA in 2001, and since then, this infection has been reported in Europe, Israel, South America, and China. In Korea, the first KPC-2-producing K. pneumoniae sequence type (ST) 11 strain was detected in 2010. We report the case of a patient with a urinary tract infection caused by KPC-2-producing K. pneumoniae. This is the second report of a KPC-2-producing K. pneumoniae infection in Korea, but the multilocus sequence type was ST258. The KPC-2-producing isolate was resistant to all tested β-lactams (including imipenem and meropenem), amikacin, tobramycin, ciprofloxacin, levofloxacin, and trimethoprim-sulfamethoxazole, but was susceptible to gentamicin, colistin, polymyxin B, and tigecycline. The KPC-2-producing isolate was negative to phenotypic extended-spectrum β-lactamase (ESBL) and AmpC detection tests and positive to modified Hodge test and carbapenemase inhibition test with aminophenylboronic acid.

UR - http://www.scopus.com/inward/record.url?scp=84863230297&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863230297&partnerID=8YFLogxK

U2 - 10.3343/kjlm.2011.31.4.298

DO - 10.3343/kjlm.2011.31.4.298

M3 - Article

VL - 31

SP - 298

EP - 301

JO - Annals of Laboratory Medicine

JF - Annals of Laboratory Medicine

SN - 2234-3806

IS - 4

ER -